Table 2 Experimental methods for detecting m6A modification.

From: The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer

Method

Name

Classification

Mechanism

Advantage

Deficiency

Reference (PMID)

MeRIP

methylated RNA immunoprecipitation sequencing

Rely on m6A antibody

MeRIP enriched the m6A-modified fragment with an anti-m6A antibody incubated with the RNA fragment for high-throughput sequencing detection of m6A

MeRIP is an earlier method for detecting m6A and facilitates the research progress of m6A

MeRIP relies on the specificity of anti-m6A antibody with a rather low resolution (at least 100nt)

22608085

22575960

PA-m6A-seq

photo-cross-linking-assisted m6A sequencing strategy

Rely on anti-m6A antibody

PA-m6A-seq metabolically incorporates 4SU into RNA and covalently cross-links 4SU with an aromatic amino acid residue adjacent to the anti-m6A antibody upon 365 nm UV irradiation

PA-m6A-seq increases the resolution of m6A up to about 23nt

PA-m6A-seq can only be used in cells due to the metabolism of 4SU

25491922

miCLIP

m6A individual-nucleotide resolution UV crosslinking and immunoprecipitation

rely on m6A antibody

The miCLIP cross-links RNA with anti-m6A antibody using 254 nm irradiation

Achieving the single nucleotide resolution for detecting m6A at transcriptome-wide level

The miCLIP identifies a limited number of m6A sites because of the low cross-linking efficiency

26121403

34157120

m6A-LAIC-seq

m6A-level and isoform-characterization sequencing

rely on m6A antibody

Utilize sequencing method in complete full-length RNAs after RNA Binding Protein Immunoprecipitation Assay by anti-m6A antibody

Quantitate m6A at transcriptome level

Mainly used to distinguish methylated from non-methylated transcripts

22575960

24713629

24981863

27376769

MAZTER-Seq/m6A-REF-seq

m6A-sensitive RNA-endoribonuclease-facilitated sequencing

m6A antibody independent

Endoribonuclease-based strategies to detect m6A

They can accurately detect m6A modifications at that single nucleotide level

MazF can only recognize specific m6A motifs (ACA), so their detection efficiency is low

31257032

31281898

DART-Seq

Deamination adjacent to RNA modification targets sequencing

m6A antibody independent

The fusion APOBEC1-YTH protein induced single nucleotide mutation in the adjacent site of m6A (C to U), so that m6A modification could be detected

DART-seq is efficient in detection and capable of detecting m6A modifications accumulated over time in cells

The binding ability between the fusion APOBEC1-YTH protein and m6A modifications may affect the detection accuracy of the targets

31548708

m6A-label-seq

A metabolic labeling method detects m6A

m6A antibody independent

The m6A-label-seq chemically labels intermediates during the biogenesis of m6A and allows the detection of m6A at a single base resolution level

The m6A-label-seq can recognize various m6A motifs at a single base resolution level

The m6A-label-seq only can be used in cellular system

32341503

32341502

m6A-SEAL

FTO-assisted m6A selective chemical labeling method

m6A antibody independent

The m6A-SEAL that couples FTO’s enzymatic oxidation of m6A to the unstable intermediate hm6A with a DTT-mediated thiol-addition reaction to generate a more stable dm6A with a sulfhydryl group, which could detect m6A effectively

The m6A-SEAL has higher sensitivity and specificity

Single base resolution is not yet implemented

32341503

32341502